Inhibition of the ERK/MAP kinase pathway attenuates heme oxygenase-1 expression and heme-mediated neuronal injury
- 1 May 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 398 (3) , 230-234
- https://doi.org/10.1016/j.neulet.2006.01.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Heme, heme oxygenase and ferritin in vascular endothelial cell injuryMolecular Nutrition & Food Research, 2005
- Heme oxygenase-2 gene deletion increases astrocyte vulnerability to heminBiochemical and Biophysical Research Communications, 2004
- c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritisJournal of Clinical Investigation, 2001
- The Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase 1/2 Pathway Is Involved in formyl-Methionyl-Leucyl-Phenylalanine-Induced p47phox Phosphorylation in Human NeutrophilsThe Journal of Immunology, 2000
- Cytokine-mediated cPLA2phosphorylation is regulated by multiple MAPK family membersFEBS Letters, 2000
- Epidermal Growth Factor Receptor Activation of Calpain Is Required for Fibroblast Motility and Occurs via an ERK/MAP Kinase Signaling PathwayJournal of Biological Chemistry, 2000
- Heme Oxygenase: Recent Advances in Understanding Its Regulation and RoleProceedings of the Association of American Physicians, 1999
- Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase KinaseJournal of Biological Chemistry, 1998
- Serum‐free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrusJournal of Neuroscience Research, 1995
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995